240 related articles for article (PubMed ID: 37367600)
1. Clorgyline Analogs Synergize with Azoles against Drug Efflux in
Toepfer S; Lackner M; Keniya MV; Zenz LM; Friemert M; Bracher F; Monk BC
J Fungi (Basel); 2023 Jun; 9(6):. PubMed ID: 37367600
[TBL] [Abstract][Full Text] [Related]
2. Functional Expression of Recombinant
Toepfer S; Lackner M; Keniya MV; Monk BC
J Fungi (Basel); 2023 Jan; 9(2):. PubMed ID: 36836283
[No Abstract] [Full Text] [Related]
3. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0006722. PubMed ID: 35343781
[TBL] [Abstract][Full Text] [Related]
5. A Zinc Cluster Transcription Factor Contributes to the Intrinsic Fluconazole Resistance of Candida auris.
Mayr EM; Ramírez-Zavala B; Krüger I; Morschhäuser J
mSphere; 2020 Apr; 5(2):. PubMed ID: 32321822
[TBL] [Abstract][Full Text] [Related]
6. Genetic Analysis of
Kim SH; Iyer KR; Pardeshi L; Muñoz JF; Robbins N; Cuomo CA; Wong KH; Cowen LE
mBio; 2019 Jan; 10(1):. PubMed ID: 30696744
[No Abstract] [Full Text] [Related]
7. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K
PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656
[TBL] [Abstract][Full Text] [Related]
8. Extracts from Argentinian native plants reverse fluconazole resistance in Candida species by inhibiting the efflux transporters Mdr1 and Cdr1.
Gil F; Laiolo J; Bayona-Pacheco B; Cannon RD; Ferreira-Pereira A; Carpinella MC
BMC Complement Med Ther; 2022 Oct; 22(1):264. PubMed ID: 36224581
[TBL] [Abstract][Full Text] [Related]
9. An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris.
Iyer KR; Camara K; Daniel-Ivad M; Trilles R; Pimentel-Elardo SM; Fossen JL; Marchillo K; Liu Z; Singh S; Muñoz JF; Kim SH; Porco JA; Cuomo CA; Williams NS; Ibrahim AS; Edwards JE; Andes DR; Nodwell JR; Brown LE; Whitesell L; Robbins N; Cowen LE
Nat Commun; 2020 Dec; 11(1):6429. PubMed ID: 33353950
[TBL] [Abstract][Full Text] [Related]
10. Potent Synergistic Interactions between Lopinavir and Azole Antifungal Drugs against Emerging Multidrug-Resistant Candida auris.
Eldesouky HE; Salama EA; Lanman NA; Hazbun TR; Seleem MN
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046487
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of the DHA1 family in Candida auris and mapping substrate repertoire of CauMdr1.
Khatoon R; Sharma S; Vishwakarma P; Saini A; Aggarwal P; Lynn AM; Prakash A; Prasad R; Banerjee A
Appl Microbiol Biotechnol; 2022 Nov; 106(21):7085-7097. PubMed ID: 36184687
[TBL] [Abstract][Full Text] [Related]
12.
Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
[TBL] [Abstract][Full Text] [Related]
13. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of Triazole Resistance upon Deletion of
Rybak JM; Doorley LA; Nishimoto AT; Barker KS; Palmer GE; Rogers PD
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718246
[No Abstract] [Full Text] [Related]
15. Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris.
Eldesouky HE; Li X; Abutaleb NS; Mohammad H; Seleem MN
Int J Antimicrob Agents; 2018 Dec; 52(6):754-761. PubMed ID: 30145250
[TBL] [Abstract][Full Text] [Related]
16. Novel
Li J; Coste AT; Liechti M; Bachmann D; Sanglard D; Lamoth F
Antimicrob Agents Chemother; 2023 May; 65(5):. PubMed ID: 33619054
[No Abstract] [Full Text] [Related]
17. Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical
El-Ganiny AM; Kamel HA; Yossef NE; Mansour B; El-Baz AM
Saudi Pharm J; 2022 Mar; 30(3):245-255. PubMed ID: 35498219
[No Abstract] [Full Text] [Related]
18. Effects of efflux pumps on antifungal activity of chitosan against
Muangsawat S; Chaiyosang P; Sinkanarak P; Sukted J; Thanyasrisung P; Matangkasombut O
J Oral Microbiol; 2024; 16(1):2357976. PubMed ID: 38813525
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance.
Carolus H; Pierson S; Muñoz JF; Subotić A; Cruz RB; Cuomo CA; Van Dijck P
mBio; 2021 Apr; 12(2):. PubMed ID: 33820824
[No Abstract] [Full Text] [Related]
20. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
